Research Increases Possibilities Of Personalizing Treatment Of Infant Osteosarcoma

Specialists have revealed the existence of genetic variants that have greater resistance to a specific treatment and a greater toxicity of the pharmaceutical drug in some child patients affected by osteosarcoma. The team investigated the mechanisms of the illness in order to obtain a personalized therapeutic treatment in the future.

Read the whole article on Science Daily

More from Science Daily